Literature DB >> 18711179

Just enough palliation: radiation dose and outcome in patients with non-small-cell lung cancer.

Henry Wagner.   

Abstract

Entities:  

Mesh:

Year:  2008        PMID: 18711179     DOI: 10.1200/JCO.2008.17.3674

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  7 in total

1.  Promoting new approaches for cancer care in the Middle East.

Authors:  M Silbermann; D E Epner; H Charalambous; L Baider; C M Puchalski; L Balducci; M Gultekin; R F Abdalla; M Daher; M R Al-Tarawneh; T J Smith
Journal:  Ann Oncol       Date:  2013-10       Impact factor: 32.976

2.  Causes of death and subsequent treatment after initial radical or palliative therapy of stage III non-small-cell lung cancer.

Authors:  A G Robinson; K Young; K Balchin; A Ashworth; T Owen
Journal:  Curr Oncol       Date:  2015-10       Impact factor: 3.677

3.  Single dose radiotherapy in soft tissue tumoral masses: just enough palliation.

Authors:  Andrés Vargas
Journal:  Rep Pract Oncol Radiother       Date:  2019-12-16

4.  Overall survival and toxicities regarding thoracic three-dimensional radiotherapy with concurrent chemotherapy for stage IV non-small cell lung cancer: results of a prospective single-center study.

Authors:  Sheng-Fa Su; Yin-Xiang Hu; Wei-Wei Ouyang; Bing Lu; Zhu Ma; Qing-Song Li; Hui-Qin Li; Yi-Chao Geng
Journal:  BMC Cancer       Date:  2013-10-12       Impact factor: 4.430

5.  The survival outcomes and prognosis of stage IV non-small-cell lung cancer treated with thoracic three-dimensional radiotherapy combined with chemotherapy.

Authors:  ShengFa Su; YinXiang Hu; WeiWei Ouyang; Zhu Ma; Bing Lu; QingSong Li; HuiQin Li; ZhiYong Wang; Yu Wang
Journal:  Radiat Oncol       Date:  2014-12-18       Impact factor: 3.481

6.  Concurrent palliative chemoradiation leads to survival and quality of life benefits in poor prognosis stage III non-small-cell lung cancer: a randomised trial by the Norwegian Lung Cancer Study Group.

Authors:  H H Strøm; R M Bremnes; S H Sundstrøm; N Helbekkmo; O Fløtten; U Aasebø
Journal:  Br J Cancer       Date:  2013-08-20       Impact factor: 7.640

7.  Radiation dose and survival of patients with stage IV non-small cell lung cancer undergoing concurrent chemotherapy and thoracic three-dimensional radiotherapy: reanalysis of the findings of a single-center prospective study.

Authors:  Wei-Wei Ouyang; Sheng-Fa Su; Yin-Xiang Hu; Bing Lu; Zhu Ma; Qing-Song Li; Hui-Qin Li; Yi-Chao Geng
Journal:  BMC Cancer       Date:  2014-07-08       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.